NUVB-WT

Insider Trades

Name	Value	Action	Price	Current Price
Mashal RobertDirector $4219 shares BuyOct 8, 2024 $2.20 --
Mashal RobertDirector $220k100k shares BuyOct 8, 2024 $2.20 --
Wang Junyuan JerryDirector, Officer: CEO, ANHEART THERAPEUTICS LTD. $163k56.4k shares SellNov 11, 2024 $2.89 --
Mashal RobertDirector $1.8k1.1k shares BuyApr 1, 2025 $1.67 --
Mashal RobertDirector $165k98.9k shares BuyApr 1, 2025 $1.67 --
Hung DavidDirector, 10 Percent Owner, Officer: PRESIDENT AND CEO $333k200k shares BuyApr 4, 2025 $1.66 --

Trade NUVB-WT

About Nuvation Bio Inc.

Nuvation Bio, Inc. operates as a biopharmaceutical firm dedicated to addressing critical unmet needs within oncology. It does so by pioneering distinctive and innovative therapeutic candidates. Its exclusive pipeline features six cutting-edge cancer treatment products, each employing a unique mechanism of action and specifically designed to combat some of the most challenging types of malignancies. David Hung established the company on March 20, 2018, and its headquarters are situated in New York, NY.

CEO: David T. Hung
IPO Date: Aug 26, 2020

Market Data

Open: $0.0641
High: $0.0641
Low: $0.0616
Volume: 6.8M
Avg Volume: 52K
52W High: $0.1444
52W Low: $0.0051

Valuation

Market Cap: $22M
Enterprise Value: $1.8B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-174M
Revenue: $63M
Net Income: $-205M
Cash: $164M
Debt: $10M

Events

EarningsMay 4

EPS est. -0.04317 · actual 0.02